The highest deals / premiums for buyouts & transactions is typically off the end of Phase 2, Yes.
Did those drugs have the same safety profile, Prior efficacy, and mountain of data that Bisantrene has? In most cases, no.
Would these things help and make BP more comfortable to act earlier? in most cases, id say yes.
Also, Are you missing the point around early FDA approval?
The highest deals / premiums for buyouts & transactions is...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
0.005(0.41%) |
Mkt cap ! $203.6M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.27 | $1.19 | $100.1K | 81.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1135 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 600 | 1 |
View Market Depth
| Last trade - 13.44pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.22 |
Change
0.005 ( 2.52 %) |
||||
| Open | High | Low | Volume | ||
| $1.22 | $1.27 | $1.20 | 15819 | ||
| Last updated 13.44pm 08/05/2024 ? | |||||
| RAC (ASX) Chart |